INmune Bio, Inc. (INMB) Tops Q1 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts INMB Hot Sheet
Join SI Premium – FREE
INmune Bio, Inc. (NASDAQ: INMB) reported Q1 EPS of ($0.20), $0.07 better than the analyst estimate of ($0.27).
For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Otis Worldwide (OTIS) Tops Q3 EPS by 4c, Beats on Revenue; Offers FY26 Guidance
- Radware Ltd. (RDWR) Tops Q3 EPS by 3c, Beats on Revenue
- Biogen (BIIB) Tops Q3 EPS by 60c, Beats on Revenue; Offers FY26 EPS Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
